These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 34750958)

  • 41. Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.
    Lee DJ; Ahmed HU; Moore CM; Emberton M; Ehdaie B
    Curr Urol Rep; 2014 Mar; 15(3):390. PubMed ID: 24430171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current role of multiparametric magnetic resonance imaging in the management of prostate cancer.
    Katelaris NC; Bolton DM; Weerakoon M; Toner L; Katelaris PM; Lawrentschuk N
    Korean J Urol; 2015 May; 56(5):337-45. PubMed ID: 25964833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding the diagnosis of prostate cancer.
    Ong XRS; Bagguley D; Yaxley JW; Azad AA; Murphy DG; Lawrentschuk N
    Med J Aust; 2020 Nov; 213(9):424-429. PubMed ID: 33047355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A cross-section of UK prostate cancer diagnostics during the coronavirus disease 2019 (COVID-19) era - a shifting paradigm?
    Stroman L; Cathcart P; Lamb A; Challacombe B; Popert R
    BJU Int; 2021 Jan; 127(1):30-34. PubMed ID: 32981180
    [No Abstract]   [Full Text] [Related]  

  • 45. A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during COVID-19.
    Hayes J; Nayak A; Gan C; Foley C; Vasdev N; Popert R; Adshead J
    BJU Int; 2023 Mar; 131(3):304-305. PubMed ID: 36445113
    [No Abstract]   [Full Text] [Related]  

  • 46. Impacts of the COVID-19 pandemic on early detection of prostate cancer in Australia.
    Ip CCK; Kealey J; Davis ID; Sengupta S
    BJU Int; 2021 Dec; 128 Suppl 3(Suppl 3):6-8. PubMed ID: 34750958
    [No Abstract]   [Full Text] [Related]  

  • 47. [Diagnostic possibilities of prostate biopsy].
    Pushkar' DIu; Govorov AV
    Urologiia; 2002; (6):46-51. PubMed ID: 12577581
    [No Abstract]   [Full Text] [Related]  

  • 48. [Prostatic neoplasms: clinical and biological aspects, histopathologic patterns].
    Puech P; Villers A; Mouton D; Leroy X; Lemaître L
    J Radiol; 2006 Feb; 87(2 Pt 2):189-200. PubMed ID: 16484944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of an increasing prostate-specific antigen level after negative prostate biopsy.
    Shinohara K; Nguyen H; Masic S
    Urol Clin North Am; 2014 May; 41(2):327-38. PubMed ID: 24725493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Melbourne Consensus Statement on the early detection of prostate cancer.
    Murphy DG; Ahlering T; Catalona WJ; Crowe H; Crowe J; Clarke N; Cooperberg M; Gillatt D; Gleave M; Loeb S; Roobol M; Sartor O; Pickles T; Wootten A; Walsh PC; Costello AJ
    BJU Int; 2014 Feb; 113(2):186-8. PubMed ID: 24206066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [MR spectroscopic imaging for evaluation of prostate cancer].
    Taouli B
    J Radiol; 2006 Feb; 87(2 Pt 2):222-7. PubMed ID: 16484947
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.